journal article·2020-08

Naftifine enhances photodynamic therapy against Staphylococcus aureus by inhibiting staphyloxanthin expression

Jing Sun, Yuxiang Zhang, Jianqiang Su, Tao Dai, Jincan Chen, Lei Zhang, Huanhuan Wang, Wenzhen Liu, Mingdong Huang, Zhuo Chen

Dyes and Pigments· Volume 179
Publisher page

Abstract

Abstract Staphyloxanthin (STX) is a virulence factor produced by Staphylococcus aureus (S. aureus) including methicillin-resistant S. aureus (MRSA), a widely distributed Gram-positive bacterium related to several clinical human infections. We herein reported that Naftifine, a broad-spectrum antifungal agent, plays an important role on photodynamic antimicrobial therapy (PACT) for S. aureus. STX attenuated the PACT effect on S. aureus in a dose-dependent manner, which probably due to its biological function of scavenging reactive oxygen species (ROS). On the contrary, the sensitivity of S. aureus to PACT was significantly improved after an incubation with Naftifine (10 μM) compared with that of S. aureus untreated with Naftifine. The reason for this phenomenon is that Naftifine inhibits STX biosynthesis and improves membrane permeability. Taken together, we identified STX as a limiting factor of PACT in S. aureus. Meanwhile, we found that the combination of PACT and Naftifine, an inhibitor of STX biosynthesis, has synergistic antibacterial effect on S. aureus, and provide a new way for the rapid and efficient treatment of S. aureus infection without drug resistance.
Source: openaire · Quality: candidate unverified · Source record ↗

Research context

OpenAlex topics: Photodynamic Therapy Research Studies · Ocular Infections and Treatments · Antimicrobial Resistance in Staphylococcus

SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.

References (29)

Show source-provided references
1. Treatment of Staphylococcus aureus infections
2. The evolution of Staphylococcus aureus10.1016/j.meegid.2008.07.007 ↗
3. Staphylococcus aureus infections: epidemiology, pathophysiology, clinical manifestations, and management10.1128/CMR.00134-14 ↗
4. Staphylococcus aureus toxins and their molecular activity in infectious diseases10.3390/toxins10060252 ↗
5. Waves of resistance: Staphylococcus aureus in the antibiotic era10.1038/nrmicro2200 ↗
6. Resistance drives antibacterial drug development10.1016/j.coph.2011.07.008 ↗
7. Antimicrobial photodynamic therapy - what we know and what we don't10.1080/1040841X.2018.1467876 ↗
8. Antimicrobial photodynamic inactivation: a bright new technique to kill resistant microbes10.1016/j.mib.2016.06.008 ↗
9. Photodynamic therapy (PDT): PDT mechanisms10.5946/ce.2013.46.1.24 ↗
10. Type I and Type II mechanisms of antimicrobial photodynamic therapy: an in vitro study on gram-negative and gram-positive bacteria10.1002/lsm.22045 ↗
11. An effective zinc phthalocyanine derivative for photodynamic antimicrobial chemotherapy10.1016/j.jlumin.2013.10.067 ↗
12. Rejuvenated photodynamic therapy for bacterial infections10.1002/adhm.201900608 ↗
13. Household light source for potent photo-dynamic antimicrobial effect and wound healing in an infective animal model10.1364/BOE.9.001006 ↗
14. Effect of photodynamic therapy on the virulence factors of Staphylococcus aureus
15. Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent10.1186/1471-2180-9-211 ↗
16. Discovering the mechanisms of strain-dependent response of Staphylococcus aureus to photoinactivation: oxidative stress toleration, endogenous porphyrin level and strain's virulence10.1016/j.pdpdt.2013.02.004 ↗
17. Structure and biosynthesis of staphyloxanthin from Staphylococcus aureus10.1074/jbc.M505070200 ↗
18. Targeting virulence factors as an antimicrobial approach: pigment inhibitors10.1002/med.21621 ↗
19. Staphyloxanthin plays a role in the fitness of Staphylococcus aureus and its ability to cope with oxidative stress10.1128/IAI.00204-06 ↗
20. Staphyloxanthin: a potential target for antivirulence therapy10.2147/IDR.S193649 ↗
21. Observations on the resistance to drying of staphylococcal strains10.1099/00222615-26-4-251 ↗
22. Ecological and genetic implications of pigmentation in Staphylococcus aureus10.1099/00221287-75-2-259 ↗
23. Staphylococcus aureus golden pigment impairs neutrophil killing and promotes virulence through its antioxidant activity10.1084/jem.20050846 ↗
24. Interactions of staphyloxanthin and enterobactin with myeloperoxidase and reactive chlorine species10.1016/j.abb.2018.03.039 ↗
25. Pentalysine beta-carbonylphthalocyanine zinc: an effective tumor-targeting photosensitizer for photodynamic therapy10.1002/cmdc.201000042 ↗
26. Rapid killing of bacteria by a new type of photosensitizer10.1007/s00253-017-8133-8 ↗
27. Pigments of Staphylococcus aureus, a series of triterpenoid carotenoids10.1128/jb.147.3.900-913.1981 ↗
28. A cholesterol biosynthesis inhibitor blocks Staphylococcus aureus virulence10.1126/science.1153018 ↗
29. Carotenoid-related alteration of cell membrane fluidity impacts Staphylococcus aureus susceptibility to host defense peptides10.1128/AAC.00680-10 ↗